StonvexLoading…
StonvexStonvexStonvexCore line items from AMBA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $390.70M | $289.83M | $181.38M | $85.87M |
Operating Income | $-82.53M | $-64.09M | $-47.85M | $-25.86M |
Net Income | $-75.86M | $-59.43M | $-20.00M | $-24.33M |
EPS (Diluted) | $-1.78 | $-1.40 | $-1.05 | $-0.58 |
Total Assets | $798.60M | $751.89M | $706.43M | $701.92M |
Total Liabilities | $203.81M | $161.78M | $129.91M | $129.20M |
Cash & Equivalents | $191.02M | $174.06M | $142.74M | $141.28M |
Free Cash Flow OCF − CapEx | $58.01M | $43.03M | $11.62M | $10.24M |
Shares Outstanding | 43.31M | 43.05M | 42.67M | 42.41M |